In a report published Friday, Canaccord Genuity analyst Eddy Hargreaves upgraded Colgate- Palmolive Company CL to Sell Hold and raised the PT from $52 to $58 after “impressive” Q3 results.
Canaccord noted the emerging market pressure in which Colgate dominated this quarter. Hargreaves specifically compares Colgate and Unilever where Unilever reported organic sales in EM of 5.9% compared with a 10.3% H1 growth. The analyst wrote, “Colgate's emerging market growth of 9.5% in Q3 followed 9.5% in Q1 and 8.5% in Q2. Group organic sales growth of 6.0% (5.0% volume, 1.0% price) was in line with expectations.”
Growth in Latin America of 9.5% exceeded Hargreave's expectations, compared to sluggish growth in North America of 1.5%. The Science Diet re-launch and Ideal Balance Launch is also notably seeing traction. Colgate- Palmolive has 45% of global shares in toothpaste, 33% in manual toothbrush and 17% in mouthwash.
Colgate- Palmolive closed at $63.04 on Wednesday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in